Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 0.57 and traded as low as GBX 0.50. Integrated Diagnostics shares last traded at GBX 0.50, with a volume of 51,611 shares changing hands.
Integrated Diagnostics Stock Performance
The company has a market cap of £2.92 million, a PE ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.38. The company has a debt-to-equity ratio of 43.40, a current ratio of 1.53 and a quick ratio of 0.75. The company has a 50-day moving average of GBX 0.56 and a 200 day moving average of GBX 0.61.
About Integrated Diagnostics
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
Read More
- Five stocks we like better than Integrated Diagnostics
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
